Clinical trial

Surgery With or Without Thalidomide in Treating Patients With Recurrent or…

NCT00019747 · National Institutes of Health Clinical Center (CC), NIH · Terminated

Key facts

NCT number NCT00019747
Title Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Official title A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients With Recurrent Colorectal Cancer
Lead sponsor National Institutes of Health Clinical Center (CC), NIH
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Colorectal Cancer
Intervention type Drug, Other, Procedure
Interventions thalidomide, adjuvant therapy, Placebo
Enrollment 39
Start date Aug 1, 1999
Primary completion Dec 1, 2008
Completion Dec 1, 2008
First posted Jan 27, 2003
Last update posted Oct 28, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies